Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | ALNY | BNTX | ||
| Company | Horizon Therapeutics | Alnylam Pharmaceuticals | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 116.34 | 248.90 | 107.87 | ||
| High | 116.38 | 248.90 | 114.32 | ||
| Low | 116.26 | 243.35 | 107.41 | ||
| Last | 116.30 | 244.89 | 113.13 | ||
| Change | +0.05 | -1.91 | +4.90 | ||
| % Change | +0.04% | -0.77% | +4.53% | ||
| Volume | 28,881,200 | 526,100 | 1,185,800 | ||
| 20-Day Average Volume | 3,994,490 | 947,190 | 1,115,130 | ||
| Previous Close | 116.25 | 246.80 | 108.23 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 263.27 | 108.62 | ||
| 20-Day Raw Stochastic | 95.09% | 24.61% | 87.05% | ||
| 20-Day Relative Strength | 80.29% | 39.83% | 53.87% | ||
| Weighted Alpha | +49.30 | +20.38 | +2.97 | ||
| Today's Opinion | 88% Buy | 8% Buy | 56% Buy | ||
| Previous Opinion | 88% Buy | 8% Buy | 40% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +3.96% since 11/15/24 | +13.45% since 11/15/24 | ||
| Low | 115.66 on 09/29/23 | 229.85 on 11/18/24 | 98.25 on 11/18/24 | ||
| High | 116.38 on 10/05/23 | 250.71 on 11/21/24 | 114.32 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | -17.40% since 10/22/24 | +2.03% since 10/22/24 | ||
| Low | 114.75 on 09/11/23 | 229.85 on 11/18/24 | 94.31 on 11/15/24 | ||
| High | 116.38 on 10/05/23 | 301.05 on 10/24/24 | 115.93 on 11/14/24 | ||
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | -11.70% since 08/22/24 | +29.69% since 08/22/24 | ||
| Low | 98.80 on 08/03/23 | 229.85 on 11/18/24 | 85.00 on 08/28/24 | ||
| High | 116.38 on 10/05/23 | 304.39 on 10/17/24 | 131.49 on 09/17/24 | ||
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | +62.29% since 05/22/24 | +10.59% since 05/22/24 | ||
| Low | 90.56 on 05/16/23 | 146.79 on 05/30/24 | 76.53 on 08/05/24 | ||
| High | 116.38 on 10/05/23 | 304.39 on 10/17/24 | 131.49 on 09/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 31,832,512 | 25,947,062 | ||
| Shares Outstanding, K | 228,995 | 128,981 | 239,740 | ||
| Annual Sales | 3,629,040,000 | 1,828,290,000 | 4,133,300,000 | ||
| Annual Net Income | 521,480,000 | -440,240,000 | 1,006,860,000 | ||
| Last Quarter Sales | 944,960,000 | 500,920,000 | 1,368,780,000 | ||
| Last Quarter Net Income | 127,070,000 | -111,570,000 | 217,830,000 | ||
| 60-Month Beta | 1.03 | 0.39 | 0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | -0.50 on 10/31/24 | 0.89 on 11/04/24 | ||
| Latest Earnings Date | 11/01/23 | 10/31/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | N/A | N/A | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 0.00 | 0.00 | ||